Shahnawaz Ali Bhat

Dr. Shahnawaz Ali Bhat


Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 September 2023 in Molecular Neurobiology
Verified
Journal Article
Closed access
PDF file
NDNawab John Dar
Nawab John Dar
UJUrmilla John
Urmilla John
NBNargis Bano
Nargis Bano
SKSameera Khan
Sameera Khan
SBShahnawaz Ali Bhat
Shahnawaz Ali Bhat

1 January 2024 in Aging and disease
Verified
Journal Article
Open access
PDF file
SKSameera Khan
Sameera Khan
NBNargis Bano
Nargis Bano
SAShakir Ahamad
Shakir Ahamad
UJUrmilla John
Urmilla John
NDNawab Dar
Nawab Dar
SBShahnawaz Ali Bhat
Shahnawaz Ali Bhat
Mitochondrial dysfunction plays a pivotal role in the development of age-related diseases, particularly neurodegenerative disorders. The etiology of mitochondrial dysfunction involves a multitude of factors that remain elusive. This review centers on elucidating the role(s) of excitotoxicity, oxytosis/ferroptosis and neurodegeneration within the context of mitochondrial bioenergetics, biogenesis, mitophagy and oxidative stress and explores their intricate interplay in the pathogenesis of neurodegenerative diseases. The effective coordination of mitochondrial turnover processes, notably mitophagy and biogenesis, is assumed to be critically important for cellular resilience and longevity. However, the age-associated decrease in mitophagy impedes the elimination of dysfunctional mitochondria, consequently impairing mitochondrial biogenesis. This deleterious cascade results in the accumulation of damaged mitochondria and deterioration of cellular functions. Both excitotoxicity and oxytosis/ferroptosis have been demonstrated to contribute significantly to the pathophysiology of neurodegenerative diseases, including Alzheimer's disease (AD), Parkinson's disease (PD), Huntington’s Disease (HD), Amyotrophic Lateral Sclerosis (ALS) and Multiple Sclerosis (MS). Excitotoxicity, characterized by excessive glutamate signaling, initiates a cascade of events involving calcium dysregulation, energy depletion, and oxidative stress and is intricately linked to mitochondrial dysfunction. Furthermore, emerging concepts surrounding oxytosis/ferroptosis underscore the importance of iron-dependent lipid peroxidation and mitochondrial engagement in the pathogenesis of neurodegeneration. This review not only discusses the individual contributions of excitotoxicity and ferroptosis but also emphasizes their convergence with mitochondrial dysfunction, a key driver of neurodegenerative diseases. Understanding the intricate crosstalk between excitotoxicity, oxytosis/ferroptosis, and mitochondrial dysfunction holds potential to pave the way for mitochondrion-targeted therapeutic strategies. Such strategies, with a focus on bioenergetics, biogenesis, mitophagy, and oxidative stress, emerge as promising avenues for therapeutic intervention.

1 April 2023 in Current Neuropharmacology
Verified
Journal Article
Open access
PDF file
SBShahnawaz Ali Bhat
Shahnawaz Ali Bhat
SAShakir Ahamad
Shakir Ahamad
NDNawab John Dar
Nawab John Dar
YSYasir Hasan Siddique
Yasir Hasan Siddique
ANAAMIR NAZIR
AAMIR NAZIR
Huntington’s disease (HD) is a rare and fatal neurodegenerative disorder with no disease modifying therapeutics. HD is characterized by extensive neuronal loss and is caused by the inherited expansion of the huntingtin (HTT) gene that encodes a toxic mutant HTT (mHTT) protein having expanded polyglutamine (polyQ) residues. Current HD therapeutics only offer symptomatic relief. Infact, Food and Drug Administration (FDA) approved two synthetic small-molecule VMAT2 inhibi-tors, tetrabenazine (1) and deutetrabenazine (2), for managing HD chorea and various other diseases in clinical trials. Therefore, the landscape of drug discovery programs for HD is evolving to discover disease-modifying HD therapeutics. Likewise, numerous natural products are being evaluated at different stages of clinical development and have shown the potential to ameliorate HD pathology. The inherent anti-inflammatory and antioxidant properties of natural products mitigate the mHTT-induced oxidative stress and neuroinflammation, improve mitochondrial functions, and augment the anti-apoptotic and pro-autophagic mechanisms for increased survival of neurons in HD. In this review, we have discussed HD pathogenesis and summarized the anti-HD clinical and pre-clinical natural products, focusing on their therapeutic effects and neuroprotective mechanisms.

9 December 2022 in Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
SAShakir Ahamad
Shakir Ahamad
SBShahnawaz Ali Bhat
Shahnawaz Ali Bhat

16 September 2021 in Neurotoxicity Research
Verified
Journal Article
Closed access
PDF file
SBShahnawaz Ali Bhat
Shahnawaz Ali Bhat
ZFZoya Fatima
Zoya Fatima
ASAnika Sood
Anika Sood
RSRakesh Shukla
Rakesh Shukla
KHKashif Hanif
Kashif Hanif

22 March 2025 in Ageing Research Reviews
Verified
Journal Article
Closed access
NBNargis Bano
Nargis Bano
SKSameera Khan
Sameera Khan
SAShakir Ahamad
Shakir Ahamad
NDNawab John Dar
Nawab John Dar
HAHamad H. Alanazi
Hamad H. Alanazi
SBShahnawaz Ali Bhat
Shahnawaz Ali Bhat